FNY Investment Advisers’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-734
| Closed | -$262K | – | 680 |
|
|
2021
Q2 | $262K | Hold |
734
| – | – | 0.1% | 160 |
|
|
2021
Q1 | $354K | Hold |
734
| – | – | 0.13% | 129 |
|
|
2020
Q4 | $458K | Buy |
734
+56
| +8% | +$34.9K | 0.12% | 139 |
|
|
2020
Q3 | $252K | Buy |
678
+250
| +58% | +$92.9K | 0.11% | 148 |
|
|
2020
Q2 | $164K | Buy |
428
+196
| +84% | +$75.1K | 0.1% | 137 |
|
|
2020
Q1 | $88K | Buy |
+232
| New | +$88K | 0.07% | 184 |
|